Endovia Health Sciences (EDVA) Other Non Operating Income (2014 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Other Non Operating Income (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.20 Bn | 133.35 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.39 Bn | 78.39 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.96 Bn | 59.78 Bn | 1.37 Bn |
| 4 | Moderna | 57.62 Bn | 52.49 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - |
| 6 | BeOne Medicines | 40.38 Bn | 35.28 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.14 Bn | 27.31 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.38 Bn | 358.27 Mn |
| 10 | Endovia Health Sciences | 831,815.23 | 589,113.23 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 244,787.00 |
| Mar 31, 2026 | 23,289.00 |
| Dec 31, 2025 | -1.34 Mn |
| Sep 30, 2025 | -341,366.00 |
| Jun 30, 2025 | -5.56 Mn |
| Mar 31, 2025 | 47,070.00 |
| Dec 31, 2024 | -2.60 Mn |
| Sep 30, 2024 | -2.05 Mn |
| Jun 30, 2024 | -1.64 Mn |
| Mar 31, 2024 | -1.42 Mn |
| Dec 31, 2023 | -5.71 Mn |
| Sep 30, 2023 | -29,406.00 |
| Jun 30, 2023 | 15,774.00 |
| Mar 31, 2023 | 140,404.00 |
| Dec 31, 2022 | -22,753.00 |
| Sep 30, 2022 | -66,035.00 |
| Jun 30, 2022 | -70,762.00 |
| Mar 31, 2022 | -85,879.00 |
| Dec 31, 2021 | -20,710.00 |
| Sep 30, 2021 | -97,664.00 |